Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis

Retina

Volumn 18, Issue 5, 1998, Pages 443-447

  Canzano, John C ^a   Reed, John B ^a   Morse, Lawrence S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytomegalovirus retinitis; Highly active antiretroviral therapy; Protease inhibitors; Vitreomacular traction syndrome

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE COUNT; MALE; RETINITIS; SYNDROME; VITREOUS DISEASE;

EID: 0032470779     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199809000-00010     Document Type: Article

References (17)

1. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:75-80.
2. Colier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-1017.
3. Kelleher AD, Carr A, Zuaders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996;173:321-329.
4. Zingman BS. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir. N Engl J Med 1996;334:1674-1675. Letter.
5. Macdonald JC, Torriani F, Morse LS, et al. Protease inhibitor therapy may obviate the need for anti-CMV therapy in selected CMV retinitis patients. J Infect Dis 1998;177:1182-1187.
6. Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 1997;277:1519-1520.
7. Karavallas MP, Lowder CY, Macdonald JC, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol 1998;116:169-175.
8. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300.
9. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997;124: 199-205.
10. Smiddy WE, Michels RG, Glaser BM, et al. Vitrectomy for macular traction caused by incomplete vitreous separation. Arch Ophthalmol 1998;106:624-628.
11. McDonald HR, Johnson RN, Schatz H. Surgical results in the vitreomacular traction syndrome. Ophthalmology 1994;101: 1397-1402.
12. Gass JDM. Stereoscopic Atlas of Macular Diseases. 4th ed. Vol. 2. St. Louis: Mosby, 1997:671-725.
13. Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye 1992;6:541-552.
14. Jaffe NS. Vitreous traction at the posterior pole of the fundus due to alterations in the vitreous posterior. Trans Am Ophthalmol Soc 1967;71:642-652.
15. Silverstein BE, Smith JH, Sykes SO, et al. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1998;125:411-415.
16. Bartlett JG. The protease inhibitors for HIV infection. Ann Intern Med 1996;124:1086-1088.
17. Hogervorst E, Jurriaans S, de Wolf F, et al. Predictors for non-and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 1995;171:811-821.